AbbVie (ABBV) Cash & Equivalents (2012 - 2026)
AbbVie's Cash & Equivalents was $10.77 billion in Q3 2026, up 91.4% from $5.63 billion a year earlier and up 64.0% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at AbbVie came in at $5.23 billion, down 5.3% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -9.2% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $5.52 billion in FY2024 (-56.9%), $12.81 billion in FY2023 (+39.3%), $9.2 billion in FY2022 (-5.6%) and $9.75 billion in FY2021 (+15.4%).
- The Q3 2026 figure marks the highest quarterly Cash & Equivalents since Q2 2024.
- Compared with a year earlier, Cash & Equivalents has increased for three straight quarters, with an average decline of 4.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2024 (growth of 169.2%); the worst was Q1 2025 (a decline of 71.4%).
- Per Business Quant data, ABBV's Cash & Equivalents in the three quarters before Q3 2026 was $6.57 billion (Q2 2026), $9.39 billion (Q1 2026) and $5.23 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.89 Bn | 1,195.51 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 663.21 Bn | 583.07 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.44 Bn | 483.45 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 363.29 Bn | 326.23 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 315.87 Bn | 289.11 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 290.06 Bn | 263.95 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.79 Bn | 201.44 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 209.43 Bn | 184.54 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Vertex Pharmaceuticals | 139.01 Bn | 110.99 Bn | 2.91 Bn | 4.98 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.77 Bn |
| Jun 30, 2026 | 6.57 Bn |
| Mar 31, 2026 | 9.39 Bn |
| Dec 31, 2025 | 5.23 Bn |
| Sep 30, 2025 | 5.63 Bn |
| Jun 30, 2025 | 6.47 Bn |
| Mar 31, 2025 | 5.18 Bn |
| Dec 31, 2024 | 5.52 Bn |
| Sep 30, 2024 | 7.26 Bn |
| Jun 30, 2024 | 13.13 Bn |
| Mar 31, 2024 | 18.07 Bn |
| Dec 31, 2023 | 12.81 Bn |
| Sep 30, 2023 | 13.29 Bn |
| Jun 30, 2023 | 8.76 Bn |
| Mar 31, 2023 | 6.71 Bn |
| Dec 31, 2022 | 9.20 Bn |
| Sep 30, 2022 | 11.83 Bn |
| Jun 30, 2022 | 8.52 Bn |
| Mar 31, 2022 | 6.10 Bn |
| Dec 31, 2021 | 9.75 Bn |
API Access
AbbVie Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();